¼±Åà - È»ìǥŰ/¿£ÅÍŰ
´Ý±â - ESC
KMLE °Ë»ö
°Ë»ö ¼³Á¤
¿Â¶óÀÎ ÀÇÇмÀû
ÀÇÇпë¾î »çÀü
ÀÇÇоà¾î
ÀÇÇлçÀü
ÇÑ¿µ/¿µÇÑ»çÀü
¿µ¿µ»çÀü
»çÀÌÆ® ¼Ò°³
Àç°Ë»ö
"programmd cell death"¿¡ ´ëÇÑ ´ëÇÑÀÇÇù ÀÇÇпë¾î ¼¼ºÎ °Ë»ö °á°úÀÔ´Ï´Ù
À̰ÍÀ» ¿øÇϼ̽À´Ï±î?
programmed cell death
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú :
15
ÆäÀÌÁö:
5
¿µ¹®
ÇѱÛ
asexual cell
¹«¼º¼¼Æ÷
acidophilic cell
È£»ê¼¼Æ÷
acinar cell
»ù²Ê¸®¼¼Æ÷, ¼¼¿±¼¼Æ÷
acinar cell carcinoma
»ù²Ê¸®¼¼Æ÷¾ÏÁ¾, ¼¼¿±¼¼Æ÷¾ÏÁ¾
acinic cell carcinoma
»ù²Ê¸®¼¼Æ÷¾ÏÁ¾, ¼¼¿±¼¼Æ÷¾ÏÁ¾
adult T-cell leukemia/lymphoma
¼ºÀÎT¼¼Æ÷¹éÇ÷º´/¸²ÇÁÁ¾
amacrine cell
¹«Ãà»è¼¼Æ÷
ameboid cell
¾Æ¸Þ¹Ù¸ð¾ç¼¼Æ÷
anaplastic large cell lymphoma
¿ªÇü¼ºÅ«¼¼Æ÷¸²ÇÁÁ¾
basal cell
¹Ù´Ú¼¼Æ÷, ±âÀú¼¼Æ÷
basal cell adenoma
¹Ù´Ú¼¼Æ÷»ùÁ¾, ±âÀú¼¼Æ÷¼±Á¾
basal cell carcinoma
¹Ù´Ú¼¼Æ÷¾ÏÁ¾, ±âÀú¼¼Æ÷¾ÏÁ¾
basal cell epithelioma
¹Ù´Ú¼¼Æ÷»óÇÇÁ¾, ±âÀú¼¼Æ÷»óÇÇÁ¾
basal cell nevus
¹Ù´Ú¼¼Æ÷¸ð¹Ý, ±âÀú¼¼Æ÷¸ð¹Ý
basal cell nevus syndrome
¹Ù´Ú¼¼Æ÷¸ð¹ÝÁõÈıº, ±âÀú¼¼Æ÷¸ð¹ÝÁõÈıº
ÀÌÀü
´ÙÀ½
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú :
15
ÆäÀÌÁö:
5
¿µ¹®
ÇѱÛ
squamous cell carcinoma
ÆíÆò¼¼Æ÷¾ÏÁ¾
squamous cell in situ carcinoma
ÆíÆò¼¼Æ÷»óÇdz»¾ÏÁ¾, ÆíÆò¼¼Æ÷¾ÏÁ¾
stellate cell
º°¼¼Æ÷
stem cell
Áٱ⼼Æ÷
supporting cell
¹öÆÀ¼¼Æ÷
sustentacular cell
(¢¡supporting cell) ¹öÆÀ¼¼Æ÷
target cell
Ç¥Àû¼¼Æ÷
transitional cell
ÀÌÇ༼Æ÷
transitional cell carcinoma
ÀÌÇ༼Æ÷¾ÏÁ¾
cell line
¼¼Æ÷ÁÖ
giant cell pneumonia
°Å´ë¼¼Æ÷Æó·Å
giant cell tumor
°Å´ë¼¼Æ÷Á¾
granular cell tumor
°ú¸³¼¼Æ÷Á¾¾ç
granulosa cell tumor
°ú¸³Ãþ¼¼Æ÷Á¾¾ç
sickle cell trait
³´¼¼Æ÷¼ÒÁú, ³´ÀûÇ÷±¸Çü¼º¼ÒÁú
ÀÌÀü
´ÙÀ½
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú :
15
ÆäÀÌÁö:
5
¿µ¹®
ÇѱÛ
antibody-dependent cell-mediated cytotoxicity
Ç×üÀÇÁ¸¼¼Æ÷¸Å°³¼¼Æ÷µ¶¼º
antibody-producing cell
Ç×ü»ý»ê¼¼Æ÷
antibody-screening cell
Ç×ü¼±º°Ç÷±¸
antigen-presenting cell
Ç׿øÀü´Þ¼¼Æ÷
antigen-reactive cell
Ç׿ø¹ÝÀÀ¼¼Æ÷
antigen-recognizing cell
Ç׿øÀÎÁö¼¼Æ÷
argentaffin cell
ģũ·ÒÀº¼¼Æ÷
argyrophilic cell
ÀºÄ£È¼¼Æ÷
asexual cell
¹«¼º¼¼Æ÷
basal cell adenoma
±âÀú¼¼Æ÷»ùÁ¾, ¹Ù´Ú¼¼Æ÷¾ÏÁ¾
basosqumaous cell acanthoma
±âÀúÆíÆò¼¼Æ÷°¡½Ã¼¼Æ÷Á¾
cell-associated antibody
¼¼Æ÷ºÎÂøÇ×ü
cell-bound antibody
(¢¡cell-fixed antibody) ¼¼Æ÷°áÇÕÇ×ü
cell-fixed antibody
¼¼Æ÷°áÇÕÇ×ü
clear cell acanthoma
Åõ¸í¼¼Æ÷°¡½Ã¼¼Æ÷Á¾
ÀÌÀü
´ÙÀ½
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú :
15
ÆäÀÌÁö:
5
¿µ¹®
ÇѱÛ
Leydig cell
·¹À̵ðÈ÷ ¼¼Æ÷
Leydig cell adenoma
·¹À̵ðÈ÷¼¼Æ÷¼±Á¾
Leydig cell tumor
·¹À̵ðÈ÷¼¼Æ÷Á¾¾ç
Leydig s cell
¶óÀ̵ðÈ÷¼¼Æ÷.
MCH => mean cell hemoglobin
Æò±ÕÀûÇ÷±¸Ç÷»ö¼Ò
MCHC => mean cell hemogiooln concentration
Æò±ÕÀûÇ÷±¸Ç÷»ö¼Ò³óµµ
MCV => mean cell volume
Æò±ÕÀûÇ÷±¸¿ëÀû
Merkel cell carcinoma
¸Þ¸£Ä̼¼Æ÷ ¾Ï(Á¾)
Mikulicz cell
¹ÌÄð¸®Áî ¼¼Æ÷
Muellers cell
¹Á·¯¼¼Æ÷, ºÎä»ì¾Æ±³¼¼Æ÷
NIH T cell
NIH T¼¼Æ÷
Paget cell
ÆÄÁ¬¼¼Æ÷
Purkinje s cell
ǮŲ¿¹¼¼Æ÷.
RBC=£¾red blood cell
ÀûÇ÷±¸.
RDW=> red cell distribution width
ÀûÇ÷±¸ºÐÆ÷Æø
ÀÌÀü
´ÙÀ½
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú :
15
ÆäÀÌÁö:
5
¿µ¹®
ÇѱÛ
natural death
ÀÚ¿¬»ç(ËöËçË×).
natural death
ÀÚ¿¬»ç(í»æÔÞÝ)
natural death
ÀÚ¿¬»ç(í»æÔÞÝ).
neonatal death
½Å»ý¾Æ»ç¸Á
neonatal death
½Å»ý¾Æ»ç¸Á(~ÞÝØÌ).
neonatal death
½Å»ý¾Æ»ç¸Á(~Ë×ËÎ).
neonatal death rate
½Å»ý¾Æ»ç¸Á·ü(~ëÒ).
neonatal death rate
½Å»ý¾Æ»ç¸Á·ü(~Ëô).
nfant,sudden infant death syndrome
¿µ¾Æ±Þ»çÁõÈıº(¿µä®ÐáÞÝñøý¦ÏØ)
phase, death
»ç¸ê±â
postoperative death
¼úÈÄ»ç(¡»ç).
postoperative death
¼úÈÄ»ç(âúýÞÝ)
prenatal death
Ãâ»ýÀü»ç¸Á
proposition of cause of death
»çÀα¸¼º(Ë×ËöË´ËÛ).
puerperal death rate
»ê¿å»ç¸Á·ü (ÊÙË×ËÎËô).
ÀÌÀü
´ÙÀ½
ÀÌ ¾Æ·¡ ºÎÅÍ´Â °á°ú°¡ ¾ø½À´Ï´Ù.
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú :
0
ÆäÀÌÁö:
5
¿µ¹®
ÇѱÛ
ÀÌÀü
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú :
0
ÆäÀÌÁö:
5
¿µ¹®
ÇѱÛ
ÀÌÀü
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú :
0
ÆäÀÌÁö:
5
¿µ¹®
ÇѱÛ
ÀÌÀü
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú :
0
ÆäÀÌÁö:
5
¿µ¹®
ÇѱÛ
ÀÌÀü
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú :
0
ÆäÀÌÁö:
5
¿µ¹®
ÇѱÛ
ÀÌÀü
ÅëÇÕ°Ë»ö ¿Ï·á
ÀÌÀü
´ÙÀ½